![Isaac Manke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Isaac Manke
Direttore/Membro del Consiglio presso
ADDEX THERAPEUTICS LTD
Patrimonio netto: 1 M $ in data 31/07/2026
Profilo
Isaac Manke is currently Chairman at Rainier Acquisition Corp., Independent Non-Executive Director at Addex Therapeutics Ltd. since 2016, Director at Renovacor Holdings, Inc., Director & Senior VP-Business Development at OnKure Therapeutics, Inc. starting 2026, and Independent Director at Q32 Bio, Inc. starting 2024.
Former roles include Director at OnKure, Inc., Karos Pharmaceuticals, Inc., True North Therapeutics, Inc., ReViral Ltd., and Independent Director at.
Chardan Healthcare Acquisition 2 Corp.
Served as Associate at Deutsche Bank Securities, Inc. from 2006 to 2007, Research Analyst at Sanford C.
Bernstein & Co. LLC, General Partner at New Leaf Venture Partners LLC from 2009 to 2019, Senior Analyst at Health Advances LLC from 2005 to 2006, and Partner at Acorn Capital Advisors LLC from 2020 to 2025.
Education includes a doctorate from Massachusetts Institute of Technology conferred in 2005 and an undergraduate degree from Minnesota State University Moorhead.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0,18% | 30/06/2026 | 53.521 ( 0,18% ) | 839 209 $ | 31/07/2026 |
1,16% | 26/08/2026 | 25.000 ( 1,16% ) | 254 000 $ | 31/07/2026 |
0,05% | 07/08/2026 | 20.583 ( 0,05% ) | 78 627 $ | 31/07/2026 |
| 18/03/2026 | 219.561 ( 0,1% ) | 11 397 $ | 31/07/2026 |
Posizioni attive di Isaac Manke
| Società | Posizione | Inizio |
|---|---|---|
| ADDEX THERAPEUTICS LTD | Direttore/Membro del Consiglio | 01/01/2016 |
Renovacor Holdings, Inc.
 Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Isaac Manke
| Società | Posizione | Fine |
|---|---|---|
Acorn Capital Advisors LLC
 Acorn Capital Advisors LLC Investment ManagersFinance Acorn Bioventures invests in small-cap public and private companies located in the United States. The firm target companies operating in the fields of health & biotechnology sectors. It provides financing for seed, cross-over financings, IPOs, registered direct offerings and PIPEs transactions. | Investitore di Private Equity | 01/07/2025 |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Investitore di Private Equity | 01/12/2019 |
Sanford C. Bernstein & Co. LLC
 Sanford C. Bernstein & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31/12/2008 |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Health Advances LLC
 Health Advances LLC Pharmaceuticals: MajorHealth Technology Provides sciences strategy consulting services to life sciences companies and investors | Corporate Officer/Principal | 01/01/2006 |
Formazione di Isaac Manke
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
86
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
OnKure, Inc.
 OnKure, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing epigenetic therapies for the treatment of cancer | Health Technology |
Sanford C. Bernstein & Co. LLC
Sanford C. Bernstein & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Addex Therapeutics Ltd.
 Addex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs | Health Technology |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Finance |
Health Advances LLC
Health Advances LLC Pharmaceuticals: MajorHealth Technology Provides sciences strategy consulting services to life sciences companies and investors | Health Technology |
Minnesota State University Moorhead
 Minnesota State University Moorhead Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karos Pharmaceuticals, Inc.
 Karos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Health Technology |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy | Health Technology |
Chardan Healthcare Acquisition 2 Corp.
 Chardan Healthcare Acquisition 2 Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Acorn Capital Advisors LLC
Acorn Capital Advisors LLC Investment ManagersFinance Acorn Bioventures invests in small-cap public and private companies located in the United States. The firm target companies operating in the fields of health & biotechnology sectors. It provides financing for seed, cross-over financings, IPOs, registered direct offerings and PIPEs transactions. | Finance |
